Caseware UK (AP4) 2024.0.164 2024.0.164 2024-03-312024-03-31Private Medical Practicefalse2023-04-0112truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 10074313 2023-04-01 2024-03-31 10074313 2022-04-01 2023-03-31 10074313 2024-03-31 10074313 2023-03-31 10074313 c:Director1 2023-04-01 2024-03-31 10074313 d:FurnitureFittings 2023-04-01 2024-03-31 10074313 d:FurnitureFittings 2024-03-31 10074313 d:FurnitureFittings 2023-03-31 10074313 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 10074313 d:OfficeEquipment 2023-04-01 2024-03-31 10074313 d:OfficeEquipment 2024-03-31 10074313 d:OfficeEquipment 2023-03-31 10074313 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 10074313 d:ComputerEquipment 2023-04-01 2024-03-31 10074313 d:ComputerEquipment 2024-03-31 10074313 d:ComputerEquipment 2023-03-31 10074313 d:ComputerEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 10074313 d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 10074313 d:CurrentFinancialInstruments 2024-03-31 10074313 d:CurrentFinancialInstruments 2023-03-31 10074313 d:Non-currentFinancialInstruments 2024-03-31 10074313 d:Non-currentFinancialInstruments 2023-03-31 10074313 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 10074313 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 10074313 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 10074313 d:Non-currentFinancialInstruments d:AfterOneYear 2023-03-31 10074313 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2024-03-31 10074313 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2023-03-31 10074313 d:ShareCapital 2024-03-31 10074313 d:ShareCapital 2023-03-31 10074313 d:RetainedEarningsAccumulatedLosses 2024-03-31 10074313 d:RetainedEarningsAccumulatedLosses 2023-03-31 10074313 c:FRS102 2023-04-01 2024-03-31 10074313 c:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 10074313 c:FullAccounts 2023-04-01 2024-03-31 10074313 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10074313 2 2023-04-01 2024-03-31 10074313 e:PoundSterling 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registered number: 10074313










MANCHESTER SPINAL CLINIC LTD








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
MANCHESTER SPINAL CLINIC LTD
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OFMANCHESTER SPINAL CLINIC LTD
FOR THE YEAR ENDED 31 MARCH 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Manchester Spinal Clinic Ltd for the year ended 31 March 2024 which comprise the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given to us.
 

This report is made solely to the Board of Directors of Manchester Spinal Clinic Ltd, as a body, in accordance with the terms of our agreement. Our work has been undertaken solely to prepare for your approval the financial statements of Manchester Spinal Clinic Ltd and state those matters that we have agreed to state to them in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Manchester Spinal Clinic Ltd and its  Board of Directors, as a body, for our work or for this report.
 
 
It is your duty to ensure that Manchester Spinal Clinic Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the Company's assets, liabilities, financial position and profit. You consider that Manchester Spinal Clinic Ltd is exempt from the statutory audit requirement for the year.
 
 
We have not been instructed to carry out an audit or review of the financial statements of Manchester Spinal Clinic Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.





Shipleys Tax Planning

26 March 2025
Page 1

 
MANCHESTER SPINAL CLINIC LTD
REGISTERED NUMBER: 10074313

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
2,417
3,920

  
2,417
3,920

Current assets
  

Debtors: amounts falling due within one year
 5 
19,369
7,469

Cash at bank and in hand
 6 
136,027
112,323

  
155,396
119,792

Creditors: amounts falling due within one year
 7 
(40,486)
(36,999)

Net current assets
  
 
 
114,910
 
 
82,793

Total assets less current liabilities
  
117,327
86,713

Creditors: amounts falling due after more than one year
 8 
-
(7,817)

  

Net assets
  
117,327
78,896


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
117,227
78,796

  
117,327
78,896


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 26 March 2025.




Page 2

 
MANCHESTER SPINAL CLINIC LTD
REGISTERED NUMBER: 10074313

BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2024

Mohammed Naveed Yasin
Director

The notes on pages 4 to 8 form part of these financial statements.

Page 3

 
MANCHESTER SPINAL CLINIC LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

Manchester Spinal Clinic Limited is a company domiciled in England & Wales, registration number 10074313. The registered office is Suite 130 Peel House, 30 The Downs, Altrincham, Cheshire, WA14 2PX.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 4

 
MANCHESTER SPINAL CLINIC LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Fixtures and fittings
-
25%
Office equipment
-
25%
Computer equipment
-
33%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 5

 
MANCHESTER SPINAL CLINIC LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.11

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2023 - 2).


4.


Tangible fixed assets





Fixtures and fittings
Office equipment
Computer equipment
Total

£
£
£
£



Cost or valuation


At 1 April 2023
280
2,477
11,230
13,987


Additions
-
-
2,934
2,934



At 31 March 2024

280
2,477
14,164
16,921



Depreciation


At 1 April 2023
210
2,272
7,585
10,067


Charge for the year on owned assets
-
179
4,258
4,437



At 31 March 2024

210
2,451
11,843
14,504



Net book value



At 31 March 2024
70
26
2,321
2,417



At 31 March 2023
70
205
3,645
3,920


5.


Debtors

2024
2023
£
£


Trade debtors
13,121
2,469

Other debtors
5,678
5,000

Prepayments and accrued income
570
-

19,369
7,469


Page 6

 
MANCHESTER SPINAL CLINIC LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

6.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
136,027
112,323

136,027
112,323



7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
23,606
14,488

Other taxation and social security
-
1,024

Other creditors
14,000
18,607

Accruals and deferred income
2,880
2,880

40,486
36,999



8.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loans
-
7,817

-
7,817



9.


Loans


Analysis of the maturity of loans is given below:


2024
2023
£
£



Amounts falling due 2-5 years

Bank loans
-
7,817


-
7,817


-
7,817


Page 7

 
MANCHESTER SPINAL CLINIC LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

10.


Related party transactions

During the year there was no movement in the loan balance owed from Altibury Ltd (a subsidiary of the company). At the balance sheet date other debtors due within one year included £5,000 (2023: £5,000) as amounts owed to the company.


11.


Controlling party

The company is controlled by the director Dr Naveed Yasin.


Page 8